Patent 7491731 was granted and assigned to Smithkline Beecham Limited on February, 2009 by the United States Patent and Trademark Office.
A crystal structure of the cfms kinase domain, co-crystal structure with a bound small molecule, as well as methods of using the same in the discovery of cfms inhibitors and in the treatment of diseases mediated by inappropriate cfms activity.